Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Generic protein (linear)
[{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa20f/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa20f/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa20d/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa20d/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa20b/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa20b/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa209/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa209/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa207/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa207/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa205/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa205/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa203/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa203/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa201/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa201/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1ff/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1ff/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1fd/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1fd/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1fb/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1fb/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1f9/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1f9/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1f7/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1f7/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1f5/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1f5/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1f3/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1f3/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1f1/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1f1/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1ef/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1ef/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1ed/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1ed/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1eb/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1eb/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1e9/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1e9/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1e7/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1e7/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1e5/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1e5/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1e3/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1e3/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1e1/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1e1/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1df/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1df/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afd5b4f2cc000281aa1dd/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afd5b4f2cc000281aa1dd/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dcd/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dcd/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dcc/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dcc/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dcb/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dcb/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dca/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dca/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc9/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc9/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc8/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc8/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc7/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc7/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc6/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc6/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc5/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc5/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc4/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc4/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc3/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc3/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc2/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc2/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc1/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc1/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dc0/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dc0/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dbf/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dbf/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dbe/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dbe/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dbd/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dbd/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dbc/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dbc/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dbb/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dbb/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829dba/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829dba/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829db9/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829db9/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829db8/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829db8/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829db7/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829db7/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829db6/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829db6/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829db5/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829db5/5c093cff5c22a91200d66050.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500a42e47b4e0027829db4/5c093cff5c22a91200d66050.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500a42e47b4e0027829db4/5c093cff5c22a91200d66050.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
philadelphia chromosome,philadelphia translocation,bcr-abl,ph,abl gene,tyrosine kinase inhibitor,tki,cml,chronic myelogenous leukemia,protein,protein
Image types
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
